Back
CRISPR Therapeutics AG Stock Price Chart
Meet America's Newest $1B Unicorn
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at
Buy
56
CRSP
CRISPR Therapeutics AG
Last Price:
$53.84
Seasonality Move:
-3%
7 Day Trial
ALL ACCESS PASS
$
7
Exxon and Chevron Have an Unlikely New Competitor
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRSP is experiencing selling pressure, which indicates risk of future bearish movement.
CRISPR Therapeutics AG Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 55.3 | Buy |
| 20-day SMA: | 56.03 | Buy |
| 50-day SMA: | 55.87 | Buy |
| 200-day SMA: | 51.83 | Buy |
| 8-day EMA: | 56.09 | Buy |
| 20-day EMA: | 55.83 | Buy |
| 50-day EMA: | 56.16 | Buy |
| 200-day EMA: | 39.46 | Buy |
CRISPR Therapeutics AG Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0 | Buy |
| Relative Strength Index (14 RSI): | 51.69 | Buy |
| Chaikin Money Flow: | -859579 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (54.25 - 57.79) | Buy |
| Bollinger Bands (100): | (52.3 - 65.36) | Sell |
CRISPR Therapeutics AG Technical Analysis
| Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 5 | Jan 6 | Jan 7 | Jan 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 23 | 24 | 26 | 29 | 30 | 31 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for CRISPR Therapeutics AG Stock
Is CRISPR Therapeutics AG Stock a Buy?
-
CRISPR Therapeutics AG share price is 56.40 while CRSP 8-day simple moving average is 55.30, which is a Buy signal.
-
The stock price of CRSP is 56.40 while CRISPR Therapeutics AG 20-day SMA is 56.03, which makes it a Buy.
-
CRISPR Therapeutics AG 50-day simple moving average is 55.87 while CRSP share price is 56.40, making it a Buy technically.
-
CRSP stock price is 56.40 and CRISPR Therapeutics AG 200-day simple moving average is 51.83, creating a Buy signal.
CRSP Technical Analysis vs Fundamental Analysis
Buy
56
CRISPR Therapeutics AG (CRSP)
is a Buy
Is CRISPR Therapeutics AG a Buy or a Sell?
-
CRISPR Therapeutics AG stock is rated a BuyThe current CRISPR Therapeutics AG [CRSP] share price is $56.40. The Score for CRSP is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
CRISPR Therapeutics AG Stock Info
Market Cap:
5.4B
Price in USD:
56.40
Share Volume:
1.5M
CRISPR Therapeutics AG 52-Week Range
52-Week High:
78.48
52-Week Low:
30.04
Buy
56
CRISPR Therapeutics AG (CRSP)
is a Buy
CRISPR Therapeutics AG Share Price Forecast
-
What is the CRISPR Therapeutics AG stock price today?The CRISPR Therapeutics AG stock price is 56.40 USD today.
-
Will CRSP stock go up or go down?CRISPR Therapeutics AG> share price is forecast to RISE/FALL based on technical indicators
-
Is CRISPR Therapeutics AG overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, CRISPR Therapeutics AG is not overvalued.
Is CRISPR Therapeutics AG Stock a Buy?
-
CRISPR Therapeutics AG share price is 56.40 while CRSP 8-day exponential moving average is 56.09, which is a Buy signal.
-
The stock price of CRSP is 56.40 while CRISPR Therapeutics AG 20-day EMA is 55.83, which makes it a Buy.
-
CRISPR Therapeutics AG 50-day exponential moving average is 56.16 while CRSP share price is 56.40, making it a Buy technically.
-
CRSP stock price is 56.40 and CRISPR Therapeutics AG 200-day simple moving average is 39.46, creating a Buy signal.
Fundamental Analysis of CRISPR Therapeutics AG
Is CRISPR Therapeutics AG a good investment?
-
Analysts estimate an earnings increase this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.74 per share, and an increase next year of $0.40 per share.
Technical Analysis of CRISPR Therapeutics AG
Should I short CRISPR Therapeutics AG stock?
-
CRSP Moving Average Covergence Divergence (MACD) indicator is 0, suggesting CRISPR Therapeutics AG is a Buy
-
CRISPR Therapeutics AG Relative Strength Index (RSI) is 51.69, which suggest CRISPR Therapeutics AG is overbought
-
The Bollinger Bands (25) for CRISPR Therapeutics AG is (54.25 - 57.79), which suggest CRISPR Therapeutics AG is a Sell
-
The Bollinger Bands (100) for CRISPR Therapeutics AG is (52.3 - 65.36), which suggest CRISPR Therapeutics AG is a Sell
* CRISPR Therapeutics AG stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.